NCT05610215View on ClinicalTrials.gov

Concomitant Hybrid Versus Catheter Ablation for Atrial Fibrillation With Hypertrophic Cardiomyopathy

NARecruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 11, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Atrial FibrillationCardiomyopathy, HypertrophicRadiofrequency Ablation
Interventions
PROCEDURE

hybrid ablation

simultaneous thoracoscopic epicardial and catheter endocardial ablation

PROCEDURE

catheter ablation

catheter endocardial ablation

Trial Locations (1)

Unknown

RECRUITING

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

All Listed Sponsors
lead

China National Center for Cardiovascular Diseases

OTHER_GOV